2. Immunology/Inflammation
  3. PD-1/PD-L1
  4. Lesabelimab

Lesabelimab  (Synonyms: LDP)

Cat. No.: HY-P99698 Purity: 97.34%
Data Sheet
SDS
COA
Technical Support

Lesabelimab (LDP) is an immunoglobulin G1-kappa anti-CD274 monoclonal antibody. CD274 is an immune checkpoint ligand, represses antitumour immunity through the interaction with PDCD1 receptor.

For research use only. We do not sell to patients.

CAS No. : 2475402-56-1

Size Price Stock Quantity
1 mg USD 200 In-stock
5 mg USD 600 In-stock
10 mg USD 960 In-stock
50 mg   Get quote  
100 mg   Get quote  

Get it tomorrow March 26 by noon. Order within 2 hrs 51 mins.

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Lesabelimab Featured Recommendations:

Lesabelimab Related Antibodies

Top Publications Citing Use of Products

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Lesabelimab (LDP) is an immunoglobulin G1-kappa anti-CD274 monoclonal antibody. CD274 is an immune checkpoint ligand, represses antitumour immunity through the interaction with PDCD1 receptor[1][2].

Isotype

Human IgG1 kappa
Recommend Isotype Controls
Species

Human
Clinical Trial
NCT NumberSponsorConditionStart DatePhase
NCT05939063Fudan University|The Third Affiliated Hospital of Soochow University|Qilu Hospital of Shandong University
Left-sided Pancreatic Cancer
August 1, 2023Not Applicable
NCT04739111Dragonboat Biopharmaceutical Company Limited|West China Hospital
Advanced Malignant Tumor
January 29, 2021Phase 1
NCT03908814Dragonboat Biopharmaceutical Company Limited|Shanghai East Hospital
Advanced Tumors
April 27, 2019Phase 1
CAS No.
Appearance

Liquid

Color

Colorless to light yellow

SMILES

[Lesabelimab]
Shipping

Shipping with dry ice.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Format
  • Human IgG1 kappa
Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

Lesabelimab Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2

Keywords:

Lesabelimab2475402-56-1LDPPD-1/PD-L1PD-1/Programmed death-ligand 1G1-kappamonoclonal antibodyimmune checkpoint ligandPDCD1Inhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Lesabelimab
Cat. No.:
HY-P99698
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

SAFETY DATA SHEET (SDS)

English - EN (251 KB) Français - FR (251 KB) Deutsch - DE (251 KB) Norwegian - NO (251 KB) Español - ES (251 KB) Swedish - SV (251 KB)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.